Hikma Pharmaceuticals PLC (HIK)

Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

1,522.00p

Buy

1,524.00p

arrow-down-12.00p (-0.79%)

Prices updated at 12 Dec 2025, 16:35 GMT
| Prices minimum 15 mins delay
|
Prices in GBX
Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.
FTSE All-Share
arrow-down-0.48%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Chairman
Mr. Said Darwazah
CEO
Mr. Riad Mishlawi
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
9,500
Head office
1 New Burlington Place
London
United Kingdom
W1S 2HR
mobile
+44 2073992760
letter
investors@hikma.uk.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Ms. Victoria Mary Hull
Non-Executive Director, Senior Independent Director
-
Mr. Mohammed Ali Khaldoun S Al-Husry
Non-Executive Director
-
Mr. Douglas Michael Hurt
Non-Executive Director
-
Ms. Nina Henderson
Non-Executive Director
-
Ms. Cynthia L. Flowers
Non-Executive Director
-
Dr. Deneen Vojta, M.D.
Non-Executive Director
-
Ms. Laura Balan
Non-Executive Director
-
Mr. Mazen Samih Taleb Darwazah
Executive Director, Vice Chairman
-
Mr. Riad Mishlawi
Executive Director, Chief Executive Officer
-
Mr. Said Darwazah
Executive Director, Chairman
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Vanguard Group Inc4,644,330
Boston Partners4,510,558
John Hancock Investment Management LLC4,335,569
JHancock Disciplined Value Intl Fd4,306,491
Boston Partners International Equity4,178,041

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
07 Nov 2025Purchase
07 Nov 2025Purchase
07 Nov 2025Purchase
06 Nov 2025Purchase
06 Nov 2025Purchase
06 Nov 2025Purchase
06 Nov 2025Purchase
06 Nov 2025Purchase
06 Nov 2025Purchase
22 Sep 2025D
16 Sep 2025Purchase
22 Aug 2025Purchase
07 Aug 2025Purchase
30 May 2025Transfer in
30 May 2025Transfer in
30 May 2025Sale
30 May 2025Transfer in
06 May 2025D
28 Feb 2025Transfer in
28 Feb 2025Transfer in
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.